Trafficking of vesicular neurotransmitter transporters

Traffic

Volumn 9, Issue 9, 2008, Pages 1425-1436

  Fei, Hao ^a   Grygoruk, Anna ^a   Brooks, Elizabeth S ^a   Chen, Audrey ^b   Krantz, David E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine; Endocytosis; Exocytosis; GABA; Glutamate; Large dense core vesicle; Monoamines; Sorting signal; Synapse; Synaptic transmission; Synaptic vesicle; Transporter

Indexed keywords

LEUCINE; PROLINE; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR GLUTAMATE TRANSPORTER 3; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; VESICULAR NEUROTRANSMITTER TRANSPORTER;

BIOGENESIS; CELL SELECTION; ENDOCYTOSIS; EXOCYTOSIS; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SECRETORY VESICLE; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

ANIMALS; ENDOCYTOSIS; HUMANS; NEUROTRANSMITTER AGENTS; NEUROTRANSMITTER TRANSPORT PROTEINS; PROTEIN TRANSPORT; SECRETORY VESICLES; SYNAPTIC TRANSMISSION;

EID: 49749127282     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2008.00771.x     Document Type: Review

References (154)

1. Hahn MK, Blakely RD. The functional impact of SLC6 transporter genetic variation. Annu Rev Pharmacol Toxicol 2007; 47: 401-441.
2. Torres GE, Amara SG. Glutamate and monoamine transporters: New visions of form and function. Curr Opin Neurobiol 2007; 17: 304-312.
3. Chaudhry FA, Boulland JL, Jenstad M, Bredahl MK, Edwards RH. Pharmacology of neurotransmitter transport into secretory vesicles. Handb Exp Pharmacol 2008; 184: 77-106.
4. Erickson JD, De Gois S, Varoqui H, Schafer MK, Weihe E. Activity-dependent regulation of vesicular glutamate and GABA transporters: A means to scale quantal size. Neurochem Int 2006; 48: 643-649.
5. Eiden LE, Schafer MK, Weihe E, Schutz B. The vesicular amine transporter family (SLC18): Amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch 2004; 447: 636-640.
6. Gasnier B. The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids. Pflugers Arch 2004; 447: 756-759.
7. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflugers Arch 2004; 447: 629-635.
8. Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004; 27: 98-103.
9. Weihe E, Eiden LE. Chemical neuroanatomy of the vesicular amine transporters. FASEB J 2000; 14: 2435-2449.
10. Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau RT Jr, Edwards RH, Storm-Mathisen J, Chaudhry FA. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 2004; 480: 264-280.
11. Fremeau RT Jr, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, Edwards RH. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A 2002; 99: 14488-14493.
12. Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002; 22: 5442-5451.
13. Schafer MK, Varoqui H, Defamie N, Weihe E, Erickson JD. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 2002; 277: 50734-50748.
14. Edwards RH. The neurotransmitter cycle and quantal size. Neuron 2007; 55: 835-858.
15. Song H-J, Ming G-L, Fon E, Bellocchio E, Edwards RH, Poo M-M. Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 1997; 18: 815-826.
16. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci U S A 2004; 101: 7158-7163.
17. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 2005; 25: 6221-6234.
18. Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W, Gershon MD, Edwards RH, Sulzer D. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 2000; 20: 7297-7306.
19. Daniels RW, Collins CA, Gelfand MV, Dant J, Brooks ES, Krantz DE, DiAntonio A. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci 2004; 24: 10466-10474.
20. Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, Amaral E, Ramsey AJ, Sotnikova TD, Ramirez MR, Kim HG, Rossato JI, Koenen J, Quan H, Cota VR, Moraes MF et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006; 51: 601-612.
21. Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N, Rhee JS. A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron 2006; 50: 575-587.
22. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, Del Rio J. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 2007; 25: 281-290.
23. Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone DE, DiAntonio A. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 2006; 49: 11-16.
24. Takamori S, Holt M, Stenius K, Lemke EA, Gronborg M, Riedel D, Urlaub H, Schenck S, Brugger B, Ringler P, Muller SA, Rammner B, Grater F, Hub JS, De Groot BL et al. Molecular anatomy of a trafficking organelle. Cell 2006; 127: 831-846.
25. Chang H-Y, Grygoruk A, Brooks ES, Ackerson LC, Maidment NT, Bainton RJ, Krantz DE. Over-expression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol Psychiatry 2006; 11: 99-113.
26. Fon EA, Pothos EN, Sun B-C, Kileen N, Sulzer D, Edwards RH. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997; 19: 1271-1283.
27. Wang Y-M, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Block CB, Miller GW, Wightman RM, Caron MC. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 1997; 19: 1285-1296.
28. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl G. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci U S A 1997; 94: 9938-9943.
29. Hall FS, Sora I, Uhl GR. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 2003; 28: 620-628.
30. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG, Wetsel WC. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 2007; 27: 10520-10529.
31. Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, Daneels G, Buist A, Cik M, van der Spek P, Kass S, Meert T, D'Hooge R, Rosenmund C, Hampson RM. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 2006; 26: 12055-12066.
32. Naves LA, Van der Kloot W. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction. J Physiol 2001; 532: 637-647.
33. Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM. Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci 2005; 25: 343-351.
34. Elhamdani A, Palfrey HC, Artalejo CR. Quantal size is dependent on stimulation frequency and calcium entry in calf chromaffin cells. Neuron 2001; 31: 819-830.
35. Yelamanchili SV, Pendyala G, Brunk I, Darna M, Albrecht U, Ahnert-Hilger G. Differential sorting of the vesicular glutamate transporter 1 into a defined vesicular pool is regulated by light signaling involving the clock gene Period2. J Biol Chem 2006; 281: 15671-15679.
36. Steinert JR, Kuromi H, Hellwig A, Knirr M, Wyatt AW, Kidokoro Y, Schuster CM. Experience-dependent formation and recruitment of large vesicles from reserve pool. Neuron 2006; 50: 723-733.
37. Liu Y, Krantz DE, Waites C, Edwards RH. Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission. Trends Cell Biol 1999; 9: 356-363.
38. Torrealba F, Carrasco MA. A review on electron microscopy and neurotransmitter systems. Brain Res Brain Res Rev 2004; 47: 5-17.
39. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Ultrastructural localization of the monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine. J Neurosci 1996; 16: 4135-4145.
40. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals. Synapse 1997; 26: 194-198.
41. Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM. The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci U S A 1995; 92: 8773-8777.
42. Agoston DV, Whittaker VP. Characterization, by size, density, osmotic fragility, and immunoaffinity, of acetylcholine- and vasoactive intestinal polypeptide-containing storage particles from neurones of the guinea-pig. J Neurochem 1989; 52: 1474-1480.
43. Lundberg JM, Fried G, Fahrenkrug J, Holmstedt B, Hokfelt T, Lagercrantz H, Lundgren G, Anggard A. Subcellular fractionation of cat submandibular gland: Comparative studies of the distribution of acetylcholine and vasoactive intestinal peptide (VIP). Neuroscience 1981; 6: 1001-1010.
44. Li H, Waites CL, Staal RG, Dobryy Y, Park J, Sulzer DL, Edwards RH. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron 2005; 48: 619-633.
45. Harkany T, Holmgren C, Hartig W, Qureshi T, Chaudhry FA, Storm-Mathisen J, Dobszay MB, Berghuis P, Schulte G, Sousa KM, Fremeau RT Jr, Edwards RH, Mackie K, Ernfors P, Zilberter Y. Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3. J Neurosci 2004; 24: 4978-4988.
46. Zilberter Y, Kaiser KM, Sakmann B. Dendritic GABA release depresses excitatory transmission between layer 2/3 pyramidal and bitufted neurons in rat neocortex. Neuron 1999; 24: 979-988.
47. Braun M, Wendt A, Karanauskaite J, Galvanovskis J, Clark A, MacDonald PE, Rorsman P. Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic beta cells. J Gen Physiol 2007; 129: 221-231.
48. Hattori T, McGeer PL, McGeer EG. Dendro axonic neurotransmission. I. Morphological sites for the synthesis, binding and release of neurotransmitters in dopaminergic dendrites in the substantia nigra and cholinergic dendrites in the neostriatum. Brain Res 1979; 170: 71-83.
49. Heeringa MJ, Abercrombie ED. Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release. J Neurochem 1995; 65: 192-200.
50. Regnier-Vigouroux A, Tooze SA, Huttner WB. Newly synthesized synaptophysin is transported to synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane. EMBO J 1991; 10: 3589-3601.
51. Hannah MJ, Schmidt AA, Huttner WB. Synaptic vesicle biogenesis. Annu Rev Cell Dev Biol 1999; 15: 733-798.
52. Prado VF, Prado MA. Signals involved in targeting membrane proteins to synaptic vesicles. Cell Mol Neurobiol 2002; 22: 565-577.
53. Ahmari SE, Buchanan J, Smith SJ. Assembly of presynaptic active zones from cytoplasmic transport packets. Nat Neurosci 2000; 3: 445-451.
54. Nakata T, Terada S, Hirokawa N. Visualization of the dynamics of synaptic vesicles and plasma membrane proteins in living axons. J Cell Biol 1998; 140: 659-674.
55. Santos MS, Barbosa J Jr, Veloso GS, Ribeiro F, Kushmerick C, Gomez MV, Ferguson SS, Prado VF, Prado MA. Trafficking of green fluorescent protein tagged-vesicular acetylcholine transporter to varicosities in a cholinergic cell line. J Neurochem 2001; 78: 1104-1113.
56. Schmidt A, Hannah MJ, Huttner WB. Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor. J Cell Biol 1997; 137: 445-458.
57. Faundez V, Horng J-T, Kelly RB. A function for the AP3 coat complex in synaptic vesicle formation from endosomes. Cell 1998; 93: 423-432.
58. Salazar G, Craige B, Love R, Kalman D, Faundez V. Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells. J Cell Sci 2005; 118: 1911-1921.
59. Salazar G, Love R, Werner E, Doucette MM, Cheng S, Levey A, Faundez V. The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation. Mol Biol Cell 2004; 15: 575-587.
60. Mullins C, Hartnell LM, Bonifacino JS. Distinct requirements for the AP-3 adaptor complex in pigment granule and synaptic vesicle biogenesis in Drosophila melanogaster. Mol Gen Genet 2000; 263: 1003-1014.
61. Kantheti P, Qiao X, Diaz ME, Peden AA, Meyer GE, Carskadon SL, Kapfhamer D, Sufalko D, Robinson MS, Noebels JL, Burmeister M. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 1998; 21: 111-122.
62. Nakatsu F, Okada M, Mori F, Kumazawa N, Iwasa H, Zhu G, Kasagi Y, Kamiya H, Harada A, Nishimura K, Takeuchi A, Miyazaki T, Watanabe M, Yuasa S, Manabe T et al. Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol 2004; 167: 293-302.
63. Kuliawat R, Arvan P. Protein targeting via the "constitutive-like" secretory pathway in isolated pancreatic islets: Passive sorting in the immature granule component. J Cell Biol 1992; 118: 521-529.
64. Tao-Cheng JH, Eiden LE. The vesicular monoamine transporter VMAT2 and vesicular acetylcholine transporter VAChT are sorted to separate vesicle populations in PC12 cells. Adv Pharmacol 1998; 42: 250-253.
65. Varoqui H, Erickson JD. The cytoplasmic tail of the vesicular acetylcholine transporter contains a synaptic vesicle targeting signal. J Biol Chem 1998; 273: 9094-9098.
66. Jahn R, Rizzoli SO. Endocytosis in neurons: Editorial introduction and overview. Traffic 2007; 8: 1121-1122.
67. Koenig JH, Ikeda K. Synaptic vesicles have two distinct recycling pathways. J Cell Biol 1996; 135: 797-808.
68. de Lange RP, de Roos AD, Borst JG. Two modes of vesicle recycling in the rat calyx of Held. J Neurosci 2003; 23: 10164-10173.
69. Ceccarelli B, Hurlbut WP, Mauro A. Turnover of transmitter and synaptic vesicles at the frog neuromuscular junction. J Cell Biol 1973; 57: 499-524.
70. Rizzoli SO, Jahn R. Kiss-and-run, collapse and 'readily retrievable' vesicles. Traffic 2007; 8: 1137-1144.
71. Blagoveshchenskaya AD, Hewitt EW, Cutler DF. Di-leucine signals mediate targeting of tyrosinase and synaptotagmin to synaptic-like microvesicles within PC12 cells. Mol Biol Cell 1999; 10: 3979-3990.
72. Heuser JE, Reese TS. Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J Cell Biol 1973; 57: 315-344.
73. Rizzoli SO, Bethani I, Zwilling D, Wenzel D, Siddiqui TJ, Brandhorst D, Jahn R. Evidence for early endosome-like fusion of recently endocytosed synaptic vesicles. Traffic 2006; 7: 1163-1176.
74. Richards DA, Guatimosim C, Betz WJ. Two endocytic recycling routes selectively fill two vesicle pools in frog motor nerve terminals. Neuron 2000; 27: 551-559.
75. Paillart C, Li J, Matthews G, Sterling P. Endocytosis and vesicle recycling at a ribbon synapse. J Neurosci 2003; 23: 4092-4099.
76. Evans GJ, Cousin MA. Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5. J Neurosci 2007; 27: 401-411.
77. Kidokoro Y, Kuromi H, Delgado R, Maureira C, Oliva C, Labarca P. Synaptic vesicle pools and plasticity of synaptic transmission at the Drosophila synapse. Brain Res Brain Res Rev 2004; 47: 18-32.
78. Rizzoli SO, Betz WJ. Synaptic vesicle pools. Nat Rev Neurosci 2005; 6: 57-69.
79. Kelly RB. Storage and release of neurotransmitters. Cell/Neuron 1993; 72/ 10: 43-53.
80. Tooze SA, Huttner WB. Cell-free protein sorting to the regulated and constitutive secretory pathways. Cell 1990; 60: 837-847.
81. Tooze SA, Flatmark T, Tooze J, Huttner WB. Characterization of the immature secretory granule, an intermediate in granule biogenesis. J Cell Biol 1991; 115: 1491-1503.
82. Dittie AS, Hajibagheri N, Tooze SA. The AP-1 adaptor complex binds to immature secretory granules from PC12 cells, and is regulated by ADP-ribosylation factor. J Cell Biol 1996; 132: 523-536.
83. Dittie AS, Thomas L, Thomas G, Tooze SA. Interaction of furin in immature secretory granules from neuroendocrine cells with the AP-1 adaptor complex is modulated by casein kinase II. EMBO J 1997; 16: 4859-4870.
84. Crump CM, Xiang Y, Thomas L, Gu F, Austin C, Tooze SA, Thomas G. PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic. EMBO J 2001; 20: 2191-2201.
85. Wan L, Molloy SS, Thomas L, Liu G, Xiang Y, Rybak SL, Thomas G. PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell 1998; 94: 205-216.
86. Lubben NB, Sahlender DA, Motley AM, Lehner PJ, Benaroch P, Robinson MS. HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. Mol Biol Cell 2007; 18: 3351-3365.
87. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 2003; 72: 395-447.
88. Letourneur F, Klausner RD. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 1992; 69: 1143-1157.
89. Bremnes B, Madsen T, Gedde-Dahl M, Bakke O. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 1994; 107: 2021-2032.
90. Pond L, Kuhn LA, Teyton L, Schutze M-P, Tainer JA, Jackson MR, Peterson PA. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem 1995; 270: 19989-19997.
91. Sandoval IV, Martinez-Arca S, Valdueza J, Palacios S, Holman GD. Distinct reading of different structural determinants modulates the dileucine-mediated transport steps of the lysosomal membrane protein LIMPII and the insulin-sensitive glucose transporter GLUT4. J Biol Chem 2000; 275: 39874-39885.
92. Dietrich J, Kastrup J, Nielsen BL, Odum N, Geisler C. Regulation and function of the CD3 gamma DXXXLL motif: A binding site for adaptor protein-1 and adaptor protein-2 in vitro. J Cell Biol 1997; 138: 271-281.
93. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 1998; 8: 1235-1238.
94. Thomas G. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 2002; 3: 753-766.
95. Tan PK, Waites C, Liu Y, Krantz DE, Edwards RH. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters. J Biol Chem 1998; 28: 17351-17360.
96. Colgan L, Liu H, Huang SY, Liu YJ. Dileucine motif is sufficient for internalization and synaptic vesicle targeting of vesicular acetylcholine transporter. Traffic 2007; 8: 512-522.
97. Yao J, Hersh LB. The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains. J Neurochem 2007; 100: 1387-1396.
98. Galli T, Haucke V. Cycling of synaptic vesicles: How far? How fast! Sci STKE 2004; 2004: Re19.
99. Wienisch M, Klingauf J. Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical. Nat Neurosci 2006; 9: 1019-1027.
100. Blagoveshchenskaya AD, Cutler DF. Sorting to synaptic-like microvesicles from early and late endosomes requires overlapping but not identical targeting signals. Mol Biol Cell 2000; 11: 1801-1814.
101. Thoidis G, Chen P, Pushkin AV, Vallega G, Leeman SE, Fine RE, Kandror KV. Two distinct populations of synaptic vesicles from rat brain. Proc Natl Acad Sci U S A 1998; 95: 183-188.
102. Krantz DE, Waites C, Oorschot V, Liu Y, Wilson RI, Tan PK, Klumperman J, Edwards RE. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles. J Cell Biol 2000; 149: 379-395.
103. Greer CL, Grygoruk A, Patton DE, Ley B, Romero-Calderon R, Chang H-Y, Houshyar R, Bainton RJ, DiAntonio A, Krantz DE. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin and octopamine. J Neurobiol 2005; 64: 239-258.
104. Waites CL, Mehta A, Tan PK, Thomas G, Edwards RH, Krantz DE. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles. J Cell Biol 2001; 152: 1159-1168.
105. Jones BG, Thomas L, Molloy SS, Thulin CD, Fry MD, Walsh KA, Thomas G. Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail. EMBO J 1995; 14: 5869-5883.
106. Krantz DE, Peter D, Liu Y, Edwards RH. Phosphorylation of a vesicular monoamine transporter by casein kinase II. J Biol Chem 1997; 272: 6752-6759.
107. Cruz-Muros I, Afonso-Oramas D, Abreu P, Rodriguez M, Gonzalez MC, Gonzalez-Hernandez T. Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging. Neurobiol Aging 2007, doi:10.1016/j.neurobiolaging.2007.09.009.
108. Han W, Rhee JS, Maximov A, Lao Y, Mashimo T, Rosenmund C, Sudhof TC. N-glycosylation is essential for vesicular targeting of synaptotagmin 1. Neuron 2004; 41: 85-99.
109. Barbosa J Jr, Ferreira LT, Martins-Silva C, Santos MS, Torres GE, Caron MG, Gomez MV, Ferguson SS, Prado MA, Prado VF. Trafficking of the vesicular acetylcholine transporter in SN56 cells: A dynamin-sensitive step and interaction with the AP-2 adaptor complex. J Neurochem 2002; 82: 1221-1228.
110. Ferreira LT, Santos MS, Kolmakova NG, Koenen J, Barbosa J Jr, Gomez MV, Guatimosim C, Zhang X, Parsons SM, Prado VF, Prado MA. Structural requirements for steady-state localization of the vesicular acetylcholine transporter. J Neurochem 2005; 94: 957-969.
111. Kim MH, Hersh LB. The vesicular acetylcholine transporter interacts with clathrin-associated adaptor complexes AP-1 and AP-2. J Biol Chem 2004; 279: 12580-12587.
112. Voglmaier SM, Kam K, Yang H, Fortin DL, Hua Z, Nicoll RA, Edwards RH. Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron 2006; 51: 71-84.
113. De Gois S, Jeanclos E, Morris M, Grewal S, Varoqui H, Erickson JD. Identification of endophilins 1 and 3 as selective binding partners for VGLUT1 and their co-localization in neocortical glutamatergic synapses: implications for vesicular glutamate transporter trafficking and excitatory vesicle formation. Cell Mol Neurobiol 2006; 26: 679-693.
114. Vinatier J, Herzog E, Plamont MA, Wojcik SM, Schmidt A, Brose N, Daviet L, El Mestikawy S, Giros B. Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. J Neurochem 2006; 97: 1111-1125.
115. Ringstad N, Gad H, Low P, Di Paolo G, Brodin L, Shupliakov O, De Camilli P. Endophilin/SH3p4 is required for the transition from early to late stages in clathrin-mediated synaptic vesicle endocytosis. Neuron 1999; 24: 143-154.
116. Guichet A, Wucherpfennig T, Dudu V, Etter S, Wilsch-Brauniger M, Hellwig A, Gonzalez-Gaitan M, Huttner WB, Schmidt AA. Essential role of endophilin A in synaptic vesicle budding at the Drosophila neuromuscular junction. EMBO J 2002; 21: 1661-1672.
117. Verstreken P, Kjaerulff O, Lloyd TE, Atkinson R, Zhou Y, Meinertzhagen IA, Bellen HJ. Endophilin mutations block clathrin-mediated endocytosis but not neurotransmitter release. Cell 2002; 109: 101-112.
118. Gallop JL, Jao CC, Kent HM, Butler PJ, Evans PR, Langen R, McMahon HT. Mechanism of endophilin N-BAR domain-mediated membrane curvature. EMBO J 2006; 25: 2898-2910.
119. Farsad K, Ringstad N, Takei K, Floyd SR, Rose K, De Camilli P. Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J Cell Biol 2001; 155: 193-200.
120. Fremeau RT Jr, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 2004; 304: 1815-1819.
121. Sandoval GM, Duerr JS, Hodgkin J, Rand JB, Ruvkun G. A genetic interaction between the vesicular acetylcholine transporter VAChT/UNC-17 and synaptobrevin/SNB-1 in C. elegans. Nat Neurosci 2006; 9: 599-601.
122. Schuske K, Palfreyman MT, Watanabe S, Jorgensen EM. UNC-46 is required for trafficking of the vesicular GABA transporter. Nat Neurosci 2007; 10: 846-853.
123. Watson F, Kiernan RS, Deavall DG, Varro A, Dimaline R. Transcriptional activation of the rat vesicular transporter 2 promoter in gastric epithelial cells: Regulation by gastrin. J Biol Chem 2000; 276: 7661-7671.
124. Catlow K, Ashurst HL, Varro A, Dimaline R. Identification of a gastrin response element in the vesicular monoamine transporter type 2 promoter and requirement of 20 S proteasome subunits for transcriptional activity. J Biol Chem 2007; 282: 17069-17077.
125. Brunk I, Blex C, Rachakonda S, Holtje M, Winter S, Pahner I, Walther DJ, Ahnert-Hilger G. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake. J Biol Chem 2006; 281: 33373-33385.
126. Brunk I, Holtje M, von Jagow B, Winter S, Sternberg J, Blex C, Pahner I, Ahnert-Hilger G. Regulation of vesicular monoamine and glutamate transporters by vesicle-associated trimeric G proteins: New jobs for long-known signal transduction molecules. Handb Exp Pharmacol 2006; 175: 305-325.
127. Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol 1994; 127: 1419-1433.
128. Liu Y, Edwards RH. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells. J Cell Biol 1997a; 139: 907-916.
129. Cho GW, Kim MH, Chai YG, Gilmor ML, Levey AI, Hersh LB. Phosphorylation of the rat vesicular acetylcholine transporter. J Biol Chem 2000; 275: 19942-19948.
130. Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 1996; 16: 2179-2190.
131. Weihe E, Tao-Cheng JH, Schafer MK, Erickson JD, Eiden LE. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Nat Acad Sci U S A 1996; 93: 3547-3552.
132. Dietrich J, Hou X, Wegener AM, Geisler C. CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J 1994; 13: 2156-2166.
133. Barbosa J Jr, Clarizia AD, Gomez MV, Romano-Silva MA, Prado VF, Prado MAM. Effect of protein kinase C activation on the release of [3H] acetylcholine in the presence of vesamicol. J Neurochem 1997; 69: 2608-2611.
134. Molloy SS, Thomas L, Kamibayashi C, Mumby MC, Thomas G. Regulation of endosome sorting by a specific PP2A isoform. J Cell Biol 1998; 142: 1399-1411.
135. Schapiro FB, Soe TT, Mallet WG, Maxfield FR. Role of cytoplasmic domain serines in intracellular trafficking of furin. Mol Biol Cell 2004; 15: 2884-2894.
136. Bedet C, Isambert MF, Henry JP, Gasnier B. Constitutive phosphorylation of the vesicular inhibitory amino acid transporter in rat central nervous system. J Neurochem 2000; 75: 1654-1663.
137. Yao J, Erickson JD, Hersh LB. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells. Traffic 2004; 5: 1006-1016.
138. Van der Kloot W. Down-regulation of quantal size at frog neuromuscular junctions: Possible roles for elevated intracellular calcium and for protein kinase C. J Neurobiol 1991; 22: 204-214.
139. Van der Kloot W, Branisteanu D. Effects of activators and inhibitors of protein kinase A on increases in quantal size at the neuromuscular junction. Pflugers Arch 1992; 420: 336-341.
140. Borowsky B, Hoffman BJ. Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure. J Biol Chem 1998; 273: 29077-29085.
141. Poyatos I, Ruberti F, Martinez-Maza R, Gimenez C, Dotti C, Zafra F. Polarized distribution of glycine transporter isoforms in epithelial and neuronal cells. Mol Cell Neurosci 2000; 15: 99-111.
142. Hanley JG, Jones EMC, Moss SJ. GABA receptor p1 subunit interacts with a novel splice variant of the glycine transporter GLYT-1. J Biol Chem 2000; 275: 840-846.
143. Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology 2005; 49: 820-830.
144. Brown JM, Hanson GR, Fleckenstein AE. Regulation of the vesicular monoamine transporter-2: A novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 2001; 296: 762-767.
145. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007; 47: 681-698.
146. Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol Exp Ther 2002; 302: 497-501.
147. Truong JG, Newman AH, Hanson GR, Fleckenstein AE. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. Eur J Pharmacol 2004; 504: 27-32.
148. Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate redistributes vesicular monoamine transporter-2: Role of dopamine receptors. J Neurosci 2002; 22: 8705-8710.
149. Hayashi M, Raimondi A, O'Toole E, Paradise S, Collesi C, Cremona O, Ferguson SM, De Camilli P. Cell- and stimulus-dependent heterogeneity of synaptic vesicle endocytic recycling mechanisms revealed by studies of dynamin 1-null neurons. Proc Natl Acad Sci U S A 2008; 105: 2175-2180.
150. Kuliawat R, Arvan P. Distinct molecular mechanisms for protein sorting within immature secretory granules of pancreatic beta-cells. J Cell Biol 1994; 126: 77-86.
151. Jung SK, Morimoto R, Otsuka M, Omote H. Transmembrane topology of vesicular glutamate transporter 2. Biol Pharm Bull 2006; 29: 547-549.
152. Fei H, Karnezis T, Reimer RJ, Krantz DE. Membrane topology of the Drosophila vesicular glutamate transporter. J Neurochem 2007; 101: 1662-1671.
153. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and characterization of the vesicular GABA transporter. Nature 1997; 389: 870-876.
154. Sagne C, El Mestikawy S, Isambert MF, Hamon M, Henry JP, Giros B, Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett 1997; 417: 177-183.